Comparison of Plasma Neurosteroid and Prolactin Levels in Patients with Schizophrenia and Healthy Individuals

Overview

Journal Scientifica (Cairo)

Publisher Wiley

Specialty Biology

Date 2016 Jun 14

PMID 27293968

Citations 4

Authors

Forough Riahi

Maryam Izadi-Mazidi

Ali Ghaffari

Elham Yousefi

Shahram Khademvatan

Affiliations

Soon will be listed here.

Abstract

Background. The present study aimed to compare plasma levels of cortisol, testosterone, dehydroepiandrosterone (DHEA), and prolactin in patients with schizophrenia and healthy individuals. Method. A total of 100 patients with schizophrenia disorder (69 men and 31 women) and 190 healthy individuals (94 men and 96 women) participated in this cross-sectional study. They were tested for hormone levels and completed demographic questionnaires. Data were analyzed using multivariate analysis of variance (MANOVA) and one-way analysis of variance. Results. Serum testosterone level was significantly higher in men with schizophrenia than in healthy men. Women with schizophrenia had a significantly higher level of testosterone and lower level of prolactin compared to healthy women. There were no significant differences in hormone levels across various subtypes of schizophrenia. No significant differences also were observed in hormones levels in patients with first-episode schizophrenia disorder compared to those in patients with recurrent episodes. Conclusion. This study indicated that abnormal testosterone and prolactin levels might be associated with pathophysiology of schizophrenia disorder.

Citing Articles

Gonadal hormone abnormalities in young patients with first-episode schizophrenia.

Hu Q, Wang J, Liang J, Xiu M, Zhang S, Wu F Int J Neuropsychopharmacol. 2024; 27(12).

PMID: 39657134 PMC: 11656025. DOI: 10.1093/ijnp/pyae063.

The Hypothalamic-Pituitary-Gonadal Axis in Men with Schizophrenia.

Matuszewska A, Kowalski K, Jawien P, Tomkalski T, Gawel-Dabrowska D, Merwid-Lad A Int J Mol Sci. 2023; 24(7).

PMID: 37047464 PMC: 10094807. DOI: 10.3390/ijms24076492.

Plasma prolactin is higher in major depressive disorder and females, and associated with anxiety, hostility, somatization, psychotic symptoms and heart rate.

Elgellaie A, Larkin T, Kaelle J, Mills J, Thomas S Compr Psychoneuroendocrinol. 2022; 6:100049.

PMID: 35757357 PMC: 9216608. DOI: 10.1016/j.cpnec.2021.100049.

Relationship of Brain-Derived Neurotrophic Factor with Interleukin-23, Testosterone and Disease Severity in Schizophrenia.

Allimuthu P, Nandeesha H, Chinniyappan R, Bhardwaz B, Blessed Raj J Indian J Clin Biochem. 2021; 36(3):365-369.

PMID: 34220013 PMC: 8215017. DOI: 10.1007/s12291-020-00880-y.

References

Melkersson K, Hulting A, Rane A . Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses. Br J Clin Pharmacol. 2001; 51(4):317-24. PMC: 2014456. DOI: 10.1046/j.1365-2125.2001.01352.x. View

Ko Y, Jung S, Joe S, Lee C, Jung H, Jung I . Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology. 2007; 32(4):385-91. DOI: 10.1016/j.psyneuen.2007.02.002. View

Potkin S, Alva G, Fleming K, Anand R, Keator D, Carreon D . A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. Am J Psychiatry. 2002; 159(2):227-37. DOI: 10.1176/appi.ajp.159.2.227. View

Goyal R, Sagar R, Ammini A, Khurana M, Alias A . Negative correlation between negative symptoms of schizophrenia and testosterone levels. Ann N Y Acad Sci. 2005; 1032:291-4. DOI: 10.1196/annals.1314.042. View

Mohammadi M, Akhondzadeh S . Schizophrenia: etiology and pharmacotherapy. IDrugs. 2005; 4(10):1167-72. View

Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein H, Steiner J . The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry. 2014; 5:47. PMC: 4032934. DOI: 10.3389/fpsyt.2014.00047. View

Meltzer H, Lee M, Jayathilake K . The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia. Neuropsychopharmacology. 2001; 24(3):278-90. DOI: 10.1016/S0893-133X(00)00201-3. View

Mason J, Giller E, Kosten T . Serum testosterone differences between patients with schizophrenia and those with affective disorder. Biol Psychiatry. 1988; 23(4):357-66. DOI: 10.1016/0006-3223(88)90286-7. View

Strous R, Maayan R, Lapidus R, Goredetsky L, Zeldich E, Kotler M . Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology. Schizophr Res. 2004; 71(2-3):427-34. DOI: 10.1016/j.schres.2004.03.005. View

10.

Khademvatan S, Khajeddin N, Izadi S, Yousefi E . Investigation of anti-Toxocara and anti-toxoplasma antibodies in patients with schizophrenia disorder. Schizophr Res Treatment. 2014; 2014:230349. PMC: 4009227. DOI: 10.1155/2014/230349. View

11.

Brophy M, Rush A, Crowley G . Cortisol, estradiol, and androgens in acutely ill paranoid schizophrenics. Biol Psychiatry. 1983; 18(5):583-90. View

12.

Ritsner M, Maayan R, Gibel A, Strous R, Modai I, Weizman A . Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Eur Neuropsychopharmacol. 2004; 14(4):267-73. DOI: 10.1016/j.euroneuro.2003.09.003. View

13.

Khademvatan S, Saki J, Khajeddin N, Izadi-Mazidi M, Beladi R, Shafiee B . Toxoplasma gondii Exposure and the Risk of Schizophrenia. Jundishapur J Microbiol. 2015; 7(11):e12776. PMC: 4332237. DOI: 10.5812/jjm.12776. View

14.

Lerer B, Ran A, Blacker M, Silver H, Weller M, Drummer D . Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction. Schizophr Res. 1988; 1(6):405-10. DOI: 10.1016/0920-9964(88)90022-9. View

15.

Brown A, Hembree W, Friedman J, Kaufmann C, Gorman J . The gonadal axis in men with schizophrenia. Psychiatry Res. 1995; 57(3):231-9. DOI: 10.1016/0165-1781(95)02643-b. View

16.

Ritsner M, Gibel A, Ram E, Maayan R, Weizman A . Alterations in DHEA metabolism in schizophrenia: two-month case-control study. Eur Neuropsychopharmacol. 2005; 16(2):137-46. DOI: 10.1016/j.euroneuro.2005.07.007. View

17.

Kaneda Y, Fujii A . Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry. 2000; 24(2):251-8. DOI: 10.1016/s0278-5846(99)00103-7. View

18.

Harris D, Wolkowitz O, Reus V . Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients. World J Biol Psychiatry. 2003; 2(2):99-102. DOI: 10.3109/15622970109027500. View

19.

Oades R, Schepker R . Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology. 1994; 19(4):373-85. DOI: 10.1016/0306-4530(94)90017-5. View

20.

Muck-Seler D, Pivac N, Jakovljevic M, Brzovic Z . Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol Psychiatry. 1999; 45(11):1433-9. DOI: 10.1016/s0006-3223(98)00174-7. View